Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M. Kuderer, Kerry L. Reynolds, Toni K. Choueiri et al.|The Lancet|2020Cited by 1.8k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisYang Li, P. Charles Lin, Laura M. DeBusk et al.|Cancer Cell|2004Cited by 1.1k
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Justin M. Balko, Mónica V. Estrada et al.|Nature Communications|2016Cited by 572
DC isoketal-modified proteins activate T cells and promote hypertensionAnnet Kirabo, David G. Harrison, Vanessa Fontana et al.|Journal of Clinical Investigation|2014Cited by 533
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B. Johnson, Christine M. Lovly, Joel Greenbowe et al.|Cancer Immunology Research|2016Cited by 493